Patents

US 7,582,314,B2

Composition and methods for the management of hyperproliferative dermatological conditions

Filling date: August 02, 2004
Issue date: September 01, 2009
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited

Abstract: The invention describes compositions and methods for the management of hyperproliferative skin conditions such as psoriasis. The preferential composition contains a natural leukotriene inhibitor selected from Boswellia serrata gum resin, its extractives, isolates or derivatives in combination with a bioavailable organic selenium nutritional supplement. These compositions are administered orally and topically to the individual human or animal in need of treatment at optimal levels to manifest the desired benefits, with no untoward side effects.

AU2004322710B2

Compositions and methods for the management of hyperproliferative dermatological conditions

Filling date: October 14, 2004
Issue date: March 02, 2006
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited

Abstract: The invention describes compositions and methods for the management of hyperproIiferative skin conditions such as psoriasis. The preferential composition contains a natural leukotriene inhibitor selected from Boswellia serrata gum resin, its extractives, isolates or derivatives in combination with a bioavailable organic selenium nutritional supplement. These compositions are administered orally and topically to the individual human or animal in need of treatment at optimal levels to manifest the desired benefits, with no untoward side effects.

AU2011200854B2

Composition for down-regulating pro-inflammatory markers

Filling date: February 28, 2011
Issue date: October 10, 2016
Inventors: Muhammed Majeed, Sarang Bani, Beena Bhat, Anjali Pandey
Assignee: Sami Labs Limited

Abstract: The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide fraction obtained from Boswellia species at specific concentrations showing enhancement in their activity as compared to boswellic acid fraction and the polysaccharide fraction alone. The invention further comprises the use of polysaccharide fraction individually or in combination with boswellic acid fraction for the inhibition of PGE2.

CA2732915C

Composition comprising boswellic acid for downregulating/inhibiting pro-inflammatory markers

Filling date: February 28, 2011
Issue date: September 05, 2017
Inventors: Muhammed Majeed, Anjali Pandey, Sarang Bani, Beena Bhat
Assignee: Muhammed Majeed

Abstract: The present invention provides a composition for down-regulating pro-inflammatory markers. The composition comprises boswellic acid fraction and polysaccharide fraction obtained from Boswellia species at specific concentrations showing enhancement in their activity as compared to boswellic acid fraction and the polysaccharide fraction alone. The invention further comprises the use of polysaccharide fraction individually or in combination with boswellic acid fraction for the inhibition of PGE2.

CN101132693

Compositions and methods for the management of hyperproliferative dermatological conditions

Filling date: October 14, 2004
Issue date: November 07, 2012
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited
EA023717B1

Use of a composition for down-regulating/inhibiting PGE2

Filling date: September 01, 2010
Issue date: February 28, 2012
Inventors: Muhammed Majeed
Assignee: Mohammed Majid (Мухаммед Маджид), Angali Pandey (Анджали Пандей), Sarang Bani (Саранг Бани)

Abstract: The present invention provides the use of a composition for pro-inflammatory markers. The composition comprising polysaccharide fraction obtained from Boswellia species for down-regulating/inhibiting PGE2

EP1791423B1

Compositions and methods for the management of hyperproliferative dermatological conditions

Filling date: October 14, 2004
Issue date: May 01, 2013
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited
IN238950

A process of preparing a synergistic composition for treating hyperproliferative dermatological conditions

Filling date: January 31, 2007
Issue date: March 02, 2010
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited

Abstract: The present invention relates to a process of preparing a synergistic composition for treating hyperproliferative dermatological conditions through oral and/or topical administration, said process comprising steps of (a) obtaining Boswellia gum extract containing boswellic acids of concentration ranging between 50 mg to 500mg; (b) obtaining selenium of concentration ranging between 10 mg to 200 mg; (c) mixing the Boswellia gum extract of step (a) with selenium of step (b), optionally along with pharmaceutically acceptable excipients; and (d) obtaining the synergistic composition for treatment of hyperproliferative dermatological conditions.

JP4820819B2

Compositions and methods for the management of hyper-proliferative dermatological conditions

Filling date: October 14, 2004
Issue date: August 29, 2011
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sabinsa Japan
NZ552027A

Compositions and methods for the management of hyperproliferative dermatological conditions

Filling date: October 14, 2004
Issue date: February 11, 2010
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited
RU2366412C2

Compositions and methods for the management of hyperproliferative dermatological conditions

Filling date: October 14, 2004
Issue date: September 10, 2009
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited
ZA200700694B

Compositions and methods for the management of hyperproliferative dermatological conditions

Filling date: October 14, 2004
Issue date: November 28, 2007
Inventors: Muhammed Majeed, Subbalakshmi Prakash
Assignee: Sami Labs Limited